Home › Funds › Millennium Management › SPRO
Millennium Management position in SPRO
SPERO THERAPEUTICS INC · Health Care
Latest position (Q2 2026)19.30K sh
Reported value held$42.65K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 61.26K | $533.00K | New |
| Q2 2022 | 314.64K | $233.00K | Add |
| Q3 2022 | 688.40K | $1.38M | Add |
| Q4 2022 | 876.40K | $1.52K | Add |
| Q1 2023 | 494.54K | $717 | Reduce |
| Q2 2023 | 373.85K | $542.08K | Reduce |
| Q3 2023 | 119.69K | $144.83K | Reduce |
| Q4 2023 | 148.86K | $218.82K | Add |
| Q1 2024 | 147.87K | $254.34K | Reduce |
| Q2 2024 | 98.52K | $128.07K | Reduce |
| Q3 2024 | 32.17K | $43.11K | Reduce |
| Q4 2025 | 24.11K | $56.17K | New |
| Q2 2026 | 19.30K | $42.65K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRO
- Vanguard Group 2.08M sh · $4.85M · Q4 2025
- Renaissance Technologies 947.90K sh · $2.09M · Q2 2026
- BlackRock Inc 594.40K sh · $1.31M · Q2 2026
- Geode Capital Management 566.33K sh · $1.25M · Q2 2026
- Two Sigma Investments 382.81K sh · $846.02K · Q2 2026
- Arrowstreet Capital 332.97K sh · $735.86K · Q2 2026
- Goldman Sachs Group 256.99K sh · $567.94K · Q2 2026
- UBS Group AG 139.68K sh · $308.69K · Q2 2026
- Northern Trust Corp 108.27K sh · $239.29K · Q2 2026
- Point72 Asset Management 104.38K sh · $230.67K · Q2 2026
- Citadel Advisors 65.60K sh · $144.98K · Q2 2026
- Invesco Ltd 64.25K sh · $141.98K · Q2 2026